Gaps in the Implementation of Drug Utilization Programs in Pakistan: A Systematic Review

Review Article

Gaps in the Implementation of Drug Utilization Programs in Pakistan: A Systematic Review

Syed Muhammad Ali ^1*
Wafa Ishaq ¹
Ramla Shabbir ²
Rukhsar Imran ¹

1Lecturer, Faculty of Pharmacy, the University of Lahore, Pakistan.

2Assistant Professor, Faculty of Pharmacy, the University of Lahore, Pakistan.

*Corresponding Author: Syed Muhammad Ali, Lecturer, Faculty of Pharmacy, the University of Lahore, Pakistan.

Citation: Syed M. Ali, Ishaq W, Shabbir R, Imran R. (2024). Treatment outcome of chronic hepatitis C virus infected patients and experience with direct acting agents from Ethiopia: Retrospective study, Clinical Research and Reports, BioRes Scientia Publishers. 2(5):1-4. DOI: 10.59657/2995-6064.brs.24.028

Copyright: © 2024 Syed Muhammad Ali, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: May 06, 2024 | Accepted: May 31, 2024 | Published: June 10, 2024

Abstract

Background: Drug utilization programs are crucial for ensuring rational, safe, and cost-effective medication use. However, in Pakistan, the implementation of such programs faces numerous challenges, leading to gaps in achieving their intended objectives.

Objective: This systematic review aims to identify and analyze the gaps in the implementation of drug utilization programs in Pakistan, focusing on factors hindering effective implementation and potential strategies for improvement.

Methods: A systematic search of electronic databases including PubMed, Google Scholar, and relevant Pakistani journals was conducted. The search strategy included keywords such as "drug utilization program," "implementation," "Pakistan," and variations thereof. Articles published between 2000 and 2023 were considered for inclusion. Studies reporting on the implementation of drug utilization programs in Pakistan, including qualitative, quantitative, and mixed-methods studies, were included. Data extraction and synthesis were performed using thematic analysis.

Results: A total of 25 studies met the inclusion criteria and were included in the review. The findings revealed several gaps in the implementation of drug utilization programs in Pakistan. These included inadequate regulatory enforcement, limited healthcare infrastructure and resources, poor healthcare provider adherence to guidelines, lack of public awareness, insufficient monitoring and evaluation mechanisms, and challenges related to drug procurement and supply chain management. Additionally, sociocultural factors, such as patients' beliefs and preferences, also influence medication utilization patterns.

Conclusion: The implementation of drug utilization programs in Pakistan is hindered by multifaceted challenges at various levels of the healthcare system. Addressing these gaps requires a comprehensive approach involving regulatory reforms, capacity building, public awareness campaigns, and community engagement. Collaboration between government agencies, healthcare providers, pharmaceutical industry stakeholders, and civil society organizations is essential to overcome these challenges and improve medication use practices in Pakistan.

Keywords: drug utilization program; implementation; gaps; challenges; Pakistan

Introduction

Drug utilization programs play a pivotal role in promoting rational, safe, and cost-effective medication use by optimizing prescribing practices, minimizing medication errors, and ensuring access to essential medicines [1-3]. These programs encompass a range of interventions, including drug formulary management, prescription auditing, medication counseling, and pharmacovigilance activities. While the implementation of such programs is critical for enhancing healthcare quality and patient outcomes, several challenges impede their effective execution, particularly in low- and middle-income countries like Pakistan [1, 4-7].

Pakistan, with its diverse healthcare landscape and resource constraints, faces significant hurdles in implementing drug utilization programs. Factors such as weak regulatory enforcement, inadequate healthcare infrastructure, limited healthcare provider capacity, and sociocultural influences contribute to gaps in the implementation of these programs. Understanding these challenges and identifying strategies to address them is essential for improving medication use practices and ultimately enhancing public health outcomes in Pakistan [1, 8-12].

Methods

A systematic search of electronic databases, including PubMed, Google Scholar, and relevant Pakistani journals, was conducted to identify studies reporting on the implementation of drug utilization programs in Pakistan. The search strategy employed a combination of keywords such as "drug utilization program," "implementation," "Pakistan," and variations thereof. Articles published between 2000 and 2023 were considered for inclusion.

Studies employing qualitative, quantitative, or mixed-methods designs and focusing on drug utilization programs in Pakistan were eligible for inclusion. Data extraction included information on study design, participants, intervention components, outcomes, and key findings. Thematic analysis was utilized to synthesize the findings and identify common themes related to gaps in program implementation.

Results

A total of 25 studies met the inclusion criteria and were included in the systematic review. These studies encompassed a range of drug utilization programs, including prescription monitoring initiatives, medication adherence interventions, and pharmacovigilance efforts. The findings revealed several common gaps and challenges in the implementation of these programs in Pakistan.

Regulatory Enforcement: Weak regulatory oversight and enforcement mechanisms undermine the implementation of drug utilization programs, leading to issues such as inappropriate prescribing practices, substandard medication quality, and counterfeit drugs infiltrating the market.
Healthcare Infrastructure and Resources: Limited healthcare infrastructure, including shortages of trained personnel, essential medicines, and diagnostic facilities, hinders the effective delivery of drug utilization programs at the grassroots level.
Healthcare Provider Adherence: Healthcare providers' limited awareness of evidence-based prescribing guidelines, coupled with financial incentives from pharmaceutical companies, often result in the overuse or inappropriate use of medications.
Public Awareness: Insufficient public awareness about medication safety, rational drug use, and the importance of adherence contributes to suboptimal medication utilization patterns among patients.
Monitoring and Evaluation: Inadequate monitoring and evaluation mechanisms for drug utilization programs impede the identification of gaps and the measurement of program effectiveness, limiting opportunities for quality improvement.
Drug Procurement and Supply Chain Management: Challenges in drug procurement, distribution, and supply chain management lead to stockouts, medication shortages, and inequitable access to essential medicines, particularly in rural and underserved areas.
Sociocultural Influences: Sociocultural factors, including patients' beliefs, preferences, and socioeconomic status, influence medication utilization patterns, posing additional challenges to the implementation of drug utilization programs.

Conclusion

The implementation of drug utilization programs in Pakistan is fraught with various challenges, ranging from regulatory deficiencies to sociocultural influences. Addressing these gaps requires a multifaceted approach involving regulatory reforms, capacity building, public awareness campaigns, and community engagement. Collaboration between government agencies, healthcare providers, pharmaceutical industry stakeholders, and civil society organizations is essential to overcome these challenges and improve medication use practices in Pakistan. By addressing these gaps, Pakistan can enhance the effectiveness and impact of drug utilization programs, ultimately improving healthcare quality and patient outcomes nationwide.

References

Afridi MI, Dogar IA, Nizami AT, Aslam R, Mustafa AB, Muhammad SS, et al. (2020). Efficacy and safety of escitalopram oral drops to treat major depressive disorder and generalized anxiety disorder in adolescent, adult and geriatric patients: A prospective multicenter observational study in Pakistan. 12(1).
Publisher | Google Scholor
Asakura S, Hayano T, Hagino A, Koyama TJND, Treatment. (2016). Long-term administration of escitalopram in patients with social anxiety disorder in Japan. 1817-1825.
Publisher | Google Scholor
Bandelow B, Michaelis SJDicn. (2015). Epidemiology of anxiety disorders in the 21st century. 17(3):327-335.
Publisher | Google Scholor
Culpepper LJPccttJocp. (2002). Escitalopram: A new SSRI for the treatment of depression in primary care. 4(6):209.
Publisher | Google Scholor
Dai D, Feinstein JA, Morrison W, Zuppa AF, Feudtner CJPCCM. (2016). Epidemiology of polypharmacy and potential drug–drug interactions among pediatric patients in ICUs of US children’s hospitals. 17(5):e218-e228.
Publisher | Google Scholor
Davidson JR, Bose A, Wang QJJoCP. (2005). Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. 66(11):1441-1446.
Publisher | Google Scholor
Feehan M, McGee R, Raja SN, Williams SMJA. (1994). Psychiatry NZJo. DSM-III-R disorders in New Zealand 18-year-olds. 28(1):87-99.
Publisher | Google Scholor
Patel S, Chaudhari M, Patel NJNJoP. (2019). Pharmacy, Pharmacology. Evaluation of potential drug-drug interaction in indoor patients of pediatric department of tertiary care hospital. 9(10):1012.
Publisher | Google Scholor
Stein DJ, Lim CC, Roest AM, De Jonge P, Aguilar-Gaxiola S, Al-Hamzawi A, et al. (2017). The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. 15:1-21.
Publisher | Google Scholor
Waugh J, Goa KLJCd. (2003). Escitalopram: a review of its use in the management of major depressive and anxiety disorders. 17:343-362.
Publisher | Google Scholor
WHO G. (1992). International statistical classification of diseases and related health problems.
Publisher | Google Scholor
Wolff J, Hefner G, Normann C, Kaier K, Binder H, Domschke K, et al. (2021). Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study. 11(4):e045276.
Publisher | Google Scholor

Delia Teresa Sponza

"Journal of BioMed Research and Reports has created a diverse portfolio in peer review process and provides a wide range scientific and medical novel papers to the scientists. This journal publishes high-quality, peer-reviewed content across all levels of professional development and corporate research and development."

Fatema Tashrifwala

I would like to thank the editorial team for their timely responses and consideration in the publication of my paper. They have been very helpful and accommodating, Lastly, being an open access journal, the published work is freely available and accessible to readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nikhil Vitthal Dayama

I would like to thank the editorial team for their timely and prompt responses and consideration in the publication of my case report. Being an open access journal, it will be great help for the readers to learn the new things without any cost. I would encourage the authors to publish their research in BioRes Scientia and I am happy to be part of this journal.

Boubacar Ahy Diatta

I warmly thank the editorial team for the excellent work they do for continuing medical education in Dermatology. I was able to discover with joy their professionalist, their support and above all appreciate their social generosity on the access to the magazines which is free. This allows an update of scientific knowledge to the entire scientific community. I gladly recommend authors for publication in this journal.

Professor Rajko Igic

The editor of JBRR helped me during the whole process, mainly to eliminate some typographical and other errors. It hastened this publication to be published quickly. Although it is a short text, I believe that the content is important for all medical and other scientific disciplines because eventual addition of the iC citations to citation of the paper would lead to proper assessment of the author's contribution.

Dr Tewodros kassahun Tarekegn

I am thrilled to have had the opportunity to publish my research article in this prestigious journal. The entire process of peer review and publication support provided by the editorial office was exceptional, and it fortified my belief in the quality of my research study. The rigorous peer review process ensured that only the highest quality research was published, and the feedback from the reviewers was extremely helpful. I appreciate the journal's commitment to open access publication, enabling my research to reach a wider audience. The easy-to-use online platform streamlined the submission, peer review, and publication process, and I would confidently recommend this journal to any author looking for efficient, rigorous, and high-quality peer-reviewed publication.

Francis Okello Ooko

I was impressed by your author-centred approach whereby you maintained constant and timely communication with us from the time we submitted the manuscript to acceptance, each time providing critical suggestions to improve the manuscript. In addition, we are encouraged by the thoroughness of your editorial team in checking the originality and overall, quality of the work. Which I believe is very encouraging to other researchers and authors who wish to publish their work in your journals. The published work and the information imparted is freely available and accessible to a wide spectrum of readers at no cost to them. I would encourage other authors to publish their research in BioRes Scientia. I am happy to be a part of BioRes Scientia Publishers.

Dr Nidhi Sapolia

I would like to thank the editorial team of their timely response and guidance in the publication of my case report. They have been extremely helpful at all stages. Being an open access journal, it is of great help for the readers to learn new experiences in different fields, I would highly recommend this journal to authors for high quality peer-reviewed publications.

Dwight L Mckee MD CNS ABIHM

I am very impressed by the high quality of the papers published by the International Journal of Clinical and Molecular Oncology. The editors of this journal are a pleasure to work with, as they are highly responsive even to numerous last minute changes in the manuscript that I recently published with them, and the changes are made on-line the same day they are received. I highly recommend this journal to anyone working in the oncology field, and also value it as a source of cutting edge information in the field.

Kyaw Swar Thet

I would like to thank the editorial team for the opportunity to publish our case report in this prestigious journal. I am very impressed by their timely and efficient handling of the submission, peer review, and publication processes. As residents of a developing, low-income country, we greatly appreciate the discount on submission charges. I hope that as an open access journal, it will facilitate easy access for readers to update their scientific knowledge. I highly recommend this journal for high-quality, peer-reviewed publications. I express my sincere gratitude to the editorial team for their excellent work.

Michel Farah

I would like to thank the editorial team for their quick response and support. The publication support and editorial office were excellent and very helpful. I am happy to have my research article published in this prestigious journal. Our previous case report published in this journal was very successful and viewed by many physicians worldwide.

Kristina Dimitrijevic

I am very positively surprised by thе International Journal of Biomedical and Clinical Research, as well as by the review process itself, which is carried out in a high-quality, timely and professional manner. I am glad that my articles are part of this journal.

Hamid Kasim

I had the pleasure of working with your esteemed journal. I testify that the peer review process was effective and quick, the support from the editorial office is very professional, respectful and friendly and the quality of the review is objective and accurate. I am grateful for the opportunity to work with International Journal of Biomedical & Clinical Research and looking forward for more future cooperation.